[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 8 sources · 1 days · First seen · Last updated

Brazil pharmaceutical industry and market trends

Overview

The Brazilian pharmaceutical sector is experiencing shifts in both market sales and industrial production. In August, pharmaceutical market sales growth slowed to 5.9% year-on-year, down from 9.5% in July, with deceleration noted in both brand-name and generic medications. Excluding GLP-1 drugs, the growth rate was 5.5%.

Simultaneously, the industry has seen an increase in domestic production. National laboratories accounted for 80.94% of commercialized medicine units in the first half of 2026, up from 77.9% in 2025. Generic medicines comprise 38.77% of the total market, totaling 1.186 billion units. This expansion is accompanied by rising demand for healthcare professionals, specifically pharmacy technicians, amid ongoing legislative efforts to establish a national minimum wage for the role.

Entities

IQVIA · Brazil · Panvel · Bradesco BBI · Alanac

Timeline

  1. [BUSINESS] 5 sources
    Brazil pharmaceutical industry sees growth in domestic production and labor demand

    Brazil's pharmaceutical sector is expanding, with domestic manufacturers controlling over 80% of the market. This growth is accompanied by rising demand and varying salary scales for pharmacy technicians.

  2. [BUSINESS] 3 sources
    Brazil pharmaceutical sales growth slows to 5.9% in August

    Brazilian pharmaceutical sales growth slowed to 5.9% in August, down from 9.5% in July, amid reduced demand for generic and brand-name drugs.

Sources

abradilan.com.br · bateaux.com · brasilemfolhas.com.br · faleconosco.net.br · guiadoinvestidor.com.br · leianoticias.com.br · portal.comunique-se.com.br · portaldobitcoin.uol.com.br